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Abstract
Introduction: The prevalence of pelvic endometriosis is high, affecting approximately 6% to 10%
of women of reproductive age. Although endometriosis has been associated with the occurrence
of menstrual cycles, it can affect between 2% to 5% of postmenopausal women.
Case presentation: We present a case of ovarian endometriosis in a 62-year-old Spanish
Caucasian woman with no previous use of hormonal therapy and no history of endometriosis or
infertility.
Conclusion: Although the reported situation is rare, it is important to be aware of endometriosis
after the menopause: post-menopausal endometriosis confers a risk of recurrence and malignant
transformation.
Introduction
Endometriosis is a common, benign, estrogen-dependent,
chronic gynecological disorder commonly associated with
pelvic pain and infertility. The prevalence of pelvic
endometriosis is high, affecting approximately 6% to 10%
of women of reproductive age [1]. Although endometrio-
sis has been associated with the occurrence of menstrual
cycles, it can affect between 2% to 5% of postmenopausal
women [2], and generally occurs as a side effect of hor-
mone use [3,4]. In these cases, a differential diagnosis to
exclude malignancies is critical. However, endometriosis
can also occur in postmenopausal women not receiving
exogenous hormones, indicating the complex pathogene-
sis of endometriosis. In clinical practice, the discrimina-
tion between endometriosis and cancer is further
complicated by the fact that some of the risk factors for
endometriosis and ovarian malignancy are similar: a low
rate of parity, infertility, late childbearing age, and a short
duration of oral contraceptive use [5]. Although there are
some reports of successful results with treatments such as
aromatase inhibitors [6], we think that surgery should be
the first step in the management of postmenopausal ovar-
ian endometriosis.
We present a case of ovarian endometriosis in a postmen-
opausal woman with no previous hormonal therapy (HT)
use and no history of endometriosis or infertility.
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A 62-year-old, non-obese, Spanish Caucasian woman pre-
sented with acyclic pelvic pain. The patient's menarche
occurred when she was 13 years old and her menopause
at 47. She denied current or previous use of HT or a prior
history of pelvic pain or dysmenorrhoea. She had no
familial or personal history of endometriosis. A physical
examination revealed a regular increased sized left adnexa
as a unique pathologic feature. A pelvic ultrasound scan
revealed a left ovarian homogeneous cystic mass of
approximately 4.4 × 2.7 × 2.7 cm in size (Figure 1). The
Doppler blood flow study suggested a benign ovarian
mass. The cancer antigen serum markers (cancer antigen
125, alpha-fetoprotein, squamous cell carcinoma, carci-
noembryonic antigen) were negative. The data suggested
a provisional diagnosis of left ovarian endometrioma.
Laparoscopy revealed a cystic left adnexal mass; no adhe-
sions or other pelvic endometriotic lesions were observed.
She was submitted to a bilateral laparoscopic salpin-
goophorectomy, and subsequent histological analysis
confirmed an ovarian endometriotic cyst (Figure 2).
Discussion
Postmenopausal endometriosis was first reported in
1950. Although a rare disease, it should be considered in
postmenopausal and women who have undergone hyster-
ectomy with classical symptoms of endometriosis, mostly
pain.
In the presence of adnexal masses in postmenopausal
women, the gynecologist must always consider the possi-
bility of a malignant ovarian tumor. In spite of being an
uncommon disease after menopause, endometriosis,
which is known to be estrogen-dependent, is been
included in the list of possible differential diagnoses when
dealing with postmenopausal women. In these cases, the
theoretical celomic metaplasia etiopathogenic mecha-
nism [7,8] could explain the occurrence of postmenopau-
sal ovarian endometriotic lesions. Another possible
explanation is endometrial stem cells from vascular
endometrial cell transportation, which occurs primarily
when endometriotic lesions appear in areas that do not
have contact with menstrual retrograde flow [9,10].
These investigations suggest that some interleukins (inter-
leukin (IL)1, IL2, IL6, IL8, IL10) and other inflammatory
mediators (tumor necrosis factor alfa, interferon gamma,
monocyte chemotactic protein-1) could play a main role
in the endometriosis pathophysiology, allowing ectopic
endometrial cells to implant and grow or triggering a
celomic metaplasia etiopathogenic mechanism. We pos-
tulate that some postmenopausal women could have a
relative immunosuppression status that allows the lesions
to establish and progress [11].
Although the condition is rare, it is important to be aware
of endometriosis after menopause. Postmenopausal
endometriosis confers a risk of recurrence and malignant
transformation. Some endometriosis lesions may predis-
pose to clear cell and endometrioid ovarian cancers. Ovar-
ian endometriomas that are 9 cm or greater in diameter
are a strong predictor for development of ovarian cancer
in postmenopausal women of 45 years of age or older
[12].
Although conclusive evidence is lacking, the risk of malig-
nant transformation appears to be lower with combined
Ultrasound imaging of the ovarian cystic lesionFigure 1
Ultrasound imaging of the ovarian cystic lesion.
Microscopic aspect of the ovarian lesionFigure 2
Microscopic aspect of the ovarian lesion.Page 2 of 3
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HT compared with estrogen-only therapy. Thus, hormone
replacement therapy should generally be reserved for
patients with severe climacteric complaints, and if indi-
cated, combined therapy should be used [13].
Conclusion
Although the reported situation is rare, it is important to
be aware of endometriosis after the menopause: post-
menopausal endometriosis confers a risk of recurrence
and malignant transformation
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